Professional Documents
Culture Documents
Review Related Literature
Review Related Literature
One community based study of 4653 close contacts of patients with covid-19
tested RT-PCR throat swabs every 48 hours during a 14 day quarantine period. Of 129
eventually diagnosed with covid-19 by RT-PCR, 92 (71.3%) had a positive test on the
first throat swab, equating to a sensitivity of 71% in this lower prevalence, community
setting.
Reference:
BMJ (2020). Interpreting a covid-19 test result. Retrieved on September 23, 2020, from
https://www.bmj.com/content/369/bmj.m1808.long
One study suggested that viral RNA levels are higher and RNA is more
frequently detected in nasal specimens as compared to oral specimens, however this
finding was based on a small number of nasal swabs tested. A COVID-19 investigation
team in the US comparing 117 pairs of nasopharyngeal and oropharyngeal specimens
from 12 patients simultaneously, found that 32 pairs were discordant with one test
positive and the other negative: the nasopharyngeal specimen tested positive in 66% of
those pairs compared with 34% for the oropharyngeal specimen. Another study did not
show higher viral RNA levels in nasopharyngeal compared with oropharyngeal
specimens.
Antibody tests currently have limited diagnostic use. They can be used as a
complement to the virus detection tests for patients presenting late after symptoms
onset to healthcare facilities and where virus detection tests are negative despite strong
indications of infection. In addition, they can potentially be used for informing the
decision on discharge of patients who recovered from SARS-CoV-2 infection but
remain RNA-positive by RT-PCR for a long time after symptoms have subsided. The
degree of protective immunity conferred by or correlated with the antibodies detected in
subjects with past SARS-CoV-2 infection is still under investigation. Once this is
clarified, such antibody tests could be, together with the direct virus detection, an
essential tool in de-escalation strategies. Currently antibody tests are used for sero-
epidemiological surveys and studies.
When rapid antigen tests are well-validated, they may be considered for the
rapid diagnosis of infected patients. However, these tests tend to have lower sensitivity
than RT-PCR, and therefore a negative rapid test may not be able to rule out infection.
They may be useful during an ongoing outbreak, when timely access to sensitive
molecular testing is unavailable, but a negative result should be interpreted by a
healthcare professional with caution and based on clinical judgement.